GWSA
RCEL icon

Global Wealth Strategies & Associates’s Avita Medical RCEL Stock Holding History

Global Wealth Strategies & Associates’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20
Closed -$74 – 378
2026
Q1 		$74 Hold
20
– – ﹤0.01% 525
2025
Q4 		$69 Hold
20
– – ﹤0.01% 533
2025
Q3 		$102 Hold
20
– – ﹤0.01% 474
2025
Q2 		$106 Hold
20
– – ﹤0.01% 367
2025
Q1 		$163 Hold
20
– – ﹤0.01% 454
2024
Q4 		$256 Hold
20
– – ﹤0.01% 376
2024
Q3 		$214 Hold
20
– – ﹤0.01% 348
2024
Q2 		$158 Hold
20
– – ﹤0.01% 324
2024
Q1 		$321 Hold
20
– – ﹤0.01% 329
2023
Q4 		$274 Hold
20
– – ﹤0.01% 294
2023
Q3 		$292 Hold
20
– – ﹤0.01% 304
2023
Q2 		$340 Hold
20
– – ﹤0.01% 292
2023
Q1 		$279 Hold
20
– – ﹤0.01% 318
2022
Q4 		$132 Buy
+20
New +$120 ﹤0.01% 321

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Global Wealth Strategies & Associates's RCEL Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 20 shares — an estimated $74 sold.

Global Wealth Strategies & Associates first reported a position in RCEL in Q4 2022 and held it in 14 quarters. The position peaked at $340 in Q2 2023. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 20 Avita Medical shares in Q2 2026, an estimated $74.
  • Global Wealth Strategies & Associates first reported a position in Avita Medical in Q4 2022 and held it in 14 quarters.
  • Global Wealth Strategies & Associates's Avita Medical position peaked at $340 in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.